Showing page 2 of 8 - total 77 results found.
-
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
https://clinicaltrials.llu.edu/trials/gore%C2%AE-cardioform-septal-occluder...This study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator education and training and transferability of trial experience to a post-market setting. Conditions … -
Gastroschisis Outcomes of Delivery (GOOD) Study
https://clinicaltrials.llu.edu/trials/gastroschisis-outcomes-delivery-good-...The objective of this study is to investigate the hypothesis that delivery at 35 0/7- 35 6/7 weeks in stable patients with gastroschisis is superior to observation and expectant management with a goal of delivery at 38 0/7 - 38 6/7 weeks. To test this … -
Intermittent Hypoxia and Caffeine in Infants Born Preterm
https://clinicaltrials.llu.edu/trials/intermittent-hypoxia-and-caffeine-inf...Intermittent Hypoxia and Caffeine in Infants Born Preterm (ICAF) Our proposal will address the critical question: is persisting intermittent hypoxia (IH) in preterm infants associated with biochemical, structural, or functional injury, and is this injury … -
Ketogenic Diet & Functional Recovery in Moderate to Severe Traumatic Brain Injury
https://clinicaltrials.llu.edu/trials/ketogenic-diet-functional-recovery-mo...Traumatic Brain Injury (TBI) represents a significant public health risk in the United States leaving many survivors with significant long term cognitive deficits and at risk for neurodegenerative diseases. Despite extensive research there are no … -
Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
https://clinicaltrials.llu.edu/trials/trial-shorten-pharmacologic-treatment...The objective of this study is to evaluate the efficacy of a rapid wean intervention compared with a slow-wean intervention in reducing the number of days of opioid treatment from the first dose of weaning to cessation of opioid among infants receiving an … -
HEALEY ALS Platform Trial - Master Protocol
https://clinicaltrials.llu.edu/trials/healey-als-platform-trial-master-prot...The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Conditions Amyotrophic Lateral Sclerosis Intervention Zilucoplan Verdiperstat … -
Role of Functional Translation After Immersive Virtual Reality Exposure in Persons With Stroke
https://clinicaltrials.llu.edu/trials/role-functional-translation-after-imm...This is a single-blinded randomized control trial aiming to explore the use of immersive virtual reality (VR) training in conjunction with real-life tasks therapy in 75 first time stroke patients with upper limb weakness. Conditions Hemiparesis as Late … -
Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
https://clinicaltrials.llu.edu/trials/fluoroscopy-radiation-reduction-durin...Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups. … -
Early Caffeine and LISA Compared to Caffeine and CPAP in Preterm Infants
https://clinicaltrials.llu.edu/trials/early-caffeine-and-lisa-compared-caff...This study is being conducted to determine whether prophylactic administration of surfactant by the Less Invasive Surfactant Administration (LISA) method reduces the need for mechanical ventilation in the first 72 hours of life when compared to early … -
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease
https://clinicaltrials.llu.edu/trials/study-assess-adverse-events-and-chang...Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement. This study will …